Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: KINIKSA PHARMACEUTICALS (UK), LTD.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-06-01 to 2024-05-31
Current total value of award: $196325.87
Description: RILONACEPT (ARCALYST) 220MG/VIL INJ